Catalyst

Slingshot members are tracking this event:

Myovan's (MYOV) Relugolix - LIBERTY 1 and LIBERTY 2 Phase 3 data in Menstrual bleeding associated with uterine fibroids to be presented at ASRM October 16

Source Link:
https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-announces-late-breaking-oral-presentation-phase

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MYOV Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Oct 16, 2019
Occurred Source:
https://asrm.confex.com/asrm/2019/meetingapp.cgi/Paper/6068
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Liberty Study, Heavy Menstrual Bleeding, Uterine Fibroids, Relugolix
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.